ZYDUS LIFESCIENCES
Back to Cashflow Statement
|
ZYDUS LIFESCIENCES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-1,810 Cr | ₹-4,400 Cr | ₹-868 Cr | ₹-2,548 Cr | ₹-1,528 Cr |
What is the latest Cash Flow from Financing Activities ratio of ZYDUS LIFESCIENCES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-1,810 Cr |
Mar2023 | ₹-4,400 Cr |
Mar2022 | ₹-868 Cr |
Mar2021 | ₹-2,548 Cr |
Mar2020 | ₹-1,528 Cr |
How is Cash Flow from Financing Activities of ZYDUS LIFESCIENCES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-1,810 Cr | Negative | |
Mar2023 | ₹-4,400 Cr | Negative | |
Mar2022 | ₹-868 Cr | Negative | |
Mar2021 | ₹-2,548 Cr | Negative | |
Mar2020 | ₹-1,528 Cr | - |
Compare Cash Flow from Financing Activities of peers of ZYDUS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ZYDUS LIFESCIENCES | ₹85,049.1 Cr | -2.7% | -5.4% | -11.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,468.0 Cr | 3.4% | 2.2% | 13.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,319.0 Cr | 5.3% | 3.9% | 51.8% | Stock Analytics | |
CIPLA | ₹122,075.0 Cr | 3.3% | 1.2% | 9.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,125.0 Cr | 4% | 6.3% | 29.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,227.9 Cr | 6.1% | 2.3% | -3.2% | Stock Analytics |
ZYDUS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ZYDUS LIFESCIENCES | -2.7% |
-5.4% |
-11.1% |
SENSEX | 7.5% |
7.6% |
7% |
You may also like the below Video Courses